Global Parkinson's Disease Treatments Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Parkinson's Disease Treatments Market Overview

• 1.1 Product Overview and Scope of Parkinson's Disease Treatments
• 1.2 Classification of Parkinson's Disease Treatments by Type
  • 1.2.1 Global Parkinson's Disease Treatments Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Parkinson's Disease Treatments Revenue Market Share by Type in 2019
  • 1.2.3 Dopamine Agonists
  • 1.2.4 Levodopa
  • 1.2.5 Glutamate Antagonist
  • 1.2.6 Apomorphine
  • 1.2.7 COMT Inhibitors Anticholinergics
  • 1.2.8 MAO-B Inhibitors
  • 1.2.9 Other Drugs
• 1.3 Global Parkinson's Disease Treatments Market by Application
  • 1.3.1 Overview: Global Parkinson's Disease Treatments Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospitals
  • 1.3.3 Healthcare Institutes
  • 1.3.4 Others
• 1.4 Global Parkinson's Disease Treatments Market by Regions
  • 1.4.1 Global Parkinson's Disease Treatments Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Parkinson's Disease Treatments (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Parkinson's Disease Treatments Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Treatments Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Treatments Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Parkinson's Disease Treatments Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Treatments Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 GSK
  • 2.1.1 GSK Details
  • 2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 GSK SWOT Analysis
  • 2.1.4 GSK Product and Services
  • 2.1.5 GSK Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Bausch Health
  • 2.2.1 Bausch Health Details
  • 2.2.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Bausch Health SWOT Analysis
  • 2.2.4 Bausch Health Product and Services
  • 2.2.5 Bausch Health Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Teva
  • 2.3.1 Teva Details
  • 2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Teva SWOT Analysis
  • 2.3.4 Teva Product and Services
  • 2.3.5 Teva Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Merck
  • 2.4.1 Merck Details
  • 2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Merck SWOT Analysis
  • 2.4.4 Merck Product and Services
  • 2.4.5 Merck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Abbvie
  • 2.5.1 Abbvie Details
  • 2.5.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Abbvie SWOT Analysis
  • 2.5.4 Abbvie Product and Services
  • 2.5.5 Abbvie Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Novartis
  • 2.6.1 Novartis Details
  • 2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Novartis SWOT Analysis
  • 2.6.4 Novartis Product and Services
  • 2.6.5 Novartis Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Sun Pharma
  • 2.7.1 Sun Pharma Details
  • 2.7.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Sun Pharma SWOT Analysis
  • 2.7.4 Sun Pharma Product and Services
  • 2.7.5 Sun Pharma Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Impax
  • 2.8.1 Impax Details
  • 2.8.2 Impax Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Impax SWOT Analysis
  • 2.8.4 Impax Product and Services
  • 2.8.5 Impax Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Boehringer Ingelheim
  • 2.9.1 Boehringer Ingelheim Details
  • 2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Boehringer Ingelheim SWOT Analysis
  • 2.9.4 Boehringer Ingelheim Product and Services
  • 2.9.5 Boehringer Ingelheim Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Lundbeck
  • 2.10.1 Lundbeck Details
  • 2.10.2 Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Lundbeck SWOT Analysis
  • 2.10.4 Lundbeck Product and Services
  • 2.10.5 Lundbeck Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Wockhardt
  • 2.11.1 Wockhardt Details
  • 2.11.2 Wockhardt Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Wockhardt SWOT Analysis
  • 2.11.4 Wockhardt Product and Services
  • 2.11.5 Wockhardt Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Acadia
  • 2.12.1 Acadia Details
  • 2.12.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Acadia SWOT Analysis
  • 2.12.4 Acadia Product and Services
  • 2.12.5 Acadia Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 UCB
  • 2.13.1 UCB Details
  • 2.13.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 UCB SWOT Analysis
  • 2.13.4 UCB Product and Services
  • 2.13.5 UCB Parkinson's Disease Treatments Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Parkinson's Disease Treatments Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Parkinson's Disease Treatments Players Market Share
  • 3.2.2 Top 10 Parkinson's Disease Treatments Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Parkinson's Disease Treatments Revenue and Market Share by Regions
• 4.2 North America Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 4.3 Europe Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 4.5 South America Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

5 North America Parkinson's Disease Treatments Revenue by Countries

• 5.1 North America Parkinson's Disease Treatments Revenue by Countries (2015-2020)
• 5.2 USA Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 5.3 Canada Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

6 Europe Parkinson's Disease Treatments Revenue by Countries

• 6.1 Europe Parkinson's Disease Treatments Revenue by Countries (2015-2020)
• 6.2 Germany Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 6.3 UK Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 6.4 France Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 6.5 Russia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 6.6 Italy Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Parkinson's Disease Treatments Revenue by Countries

• 7.1 Asia-Pacific Parkinson's Disease Treatments Revenue by Countries (2015-2020)
• 7.2 China Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 7.3 Japan Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 7.4 Korea Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 7.5 India Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

8 South America Parkinson's Disease Treatments Revenue by Countries

• 8.1 South America Parkinson's Disease Treatments Revenue by Countries (2015-2020)
• 8.2 Brazil Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Parkinson's Disease Treatments by Countries

• 9.1 Middle East & Africa Parkinson's Disease Treatments Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 9.3 UAE Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Parkinson's Disease Treatments Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Parkinson's Disease Treatments Revenue and Market Share by Type (2015-2020)
• 10.2 Global Parkinson's Disease Treatments Market Forecast by Type (2019-2024)
• 10.3 Dopamine Agonists Revenue Growth Rate (2015-2025)
• 10.4 Levodopa Revenue Growth Rate (2015-2025)
• 10.5 Glutamate Antagonist Revenue Growth Rate (2015-2025)
• 10.6 Apomorphine Revenue Growth Rate (2015-2025)
• 10.7 COMT Inhibitors Anticholinergics Revenue Growth Rate (2015-2025)
• 10.8 MAO-B Inhibitors Revenue Growth Rate (2015-2025)
• 10.9 Other Drugs Revenue Growth Rate (2015-2025)

11 Global Parkinson's Disease Treatments Market Segment by Application

• 11.1 Global Parkinson's Disease Treatments Revenue Market Share by Application (2015-2020)
• 11.2 Parkinson's Disease Treatments Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2015-2020)
• 11.4 Healthcare Institutes Revenue Growth (2015-2020)
• 11.5 Others Revenue Growth (2015-2020)

12 Global Parkinson's Disease Treatments Market Size Forecast (2021-2025)

• 12.1 Global Parkinson's Disease Treatments Market Size Forecast (2021-2025)
• 12.2 Global Parkinson's Disease Treatments Market Forecast by Regions (2021-2025)
• 12.3 North America Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
• 12.4 Europe Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
• 12.6 South America Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Parkinson's Disease Treatments Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer